Pre-solicitationPosted May 1, 2026·Responses due May 15, 2026

FDA Third Party Tobacco Retailer Inspection Services (Region 4)

FDA · FDA OFFICE OF ACQ GRANT SVCS

Stage
Early notice (sources sought, presolicitation or special notice)
NAICS
561611
Value
Not stated
Solicitation
75F40126R00040
Set-aside
Small Business Set Aside - Total
PSC
H399
Place
North Bethesda, MD, USA
Contact
Jennifer Mun (jennifer.mun@fda.hhs.gov)
Loading your pipeline and notes…
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation 75F40126R00040 in this department, oldest first.

Early notice
  • May 1, 2026 · this notice
    Pre-solicitation
Solicitation
  • Jul 1, 2026
    Solicitation
    Open
  • Jul 2, 2026
    Solicitation
    Open
  • Jul 22, 2026
    Solicitation
    Open
  • Jul 23, 2026
    Solicitation
    Open
Award
Not yet. Too few past cases at this agency to estimate timing (3 found; 10 needed).

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Answer the notice: this is when the requirement can still be shaped.
  • Contact the contracting officer named on the notice.
  • Check who won similar work; they are the likely bidders.

What the notice says

On June 22, 2009, the President signed the Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act or TCA) into law (Public Law 111-31). The Tobacco Control Act amended the Federal Food, Drug, and Cosmetic Act (FD&C Act) and granted the Food and Drug Administration (FDA) authority to regulate the manufacture, marketing, sale, and distribution of tobacco products to protect public health and to reduce tobacco use by youth. FDA conducts compliance check inspections of tobacco retail establishments to help determine a retailer�s compliance with federal laws and regulations, includi… (show all)

ng the Federal Food, Drug, and Cosmetic Act, as amended by the Tobacco Control Act, and associated regulations. To the extent feasible, FDA will contract with a state or territory to conduct compliance check inspections of tobacco retailers, as required under 21 U.S.C. 372(a)(l)(B)(i). FDA issues contracts with a state or territory to assist with compliance check inspections of retail establishments. FDA has a goal of establishing a contract, where feasible, with every U.S. state and territory. When FDA could not contract with states and territories, FDA has awarded contracts to third-party entities that are able to hire commissionable inspectors to do compliance check inspections of tobacco retailers in those jurisdictions. FDA currently requires third-party, tobacco retailer inspection services. Task orders will be issued under this required Indefinite Delivery Indefinite Quantity (IDIQ) Contract to perform the requirements identified in the Performance Work Statement (PWS).

Who won similar work

24 award notices on SAM.gov in the last 24 months. Matched by: Same agency (FDA), any industry: a loose match.

Loose match: same agency, any industry. Read the titles before treating these as competitors.

Single-winner award sizes (24): middle half $402K to $19.1M, median $2.6M; range $82K to $120.8M.

WinnerAwardsValueLast
Please_See_Spreadsheet Silver Spring MD 20993 USA3$153.2MOct 8, 2026
DCT, INCORPORATED1$52.8MSep 15, 2026
TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES LLC1$50.0MSep 16, 2025
NATI-NVE Support Services, LLC1$49.0MMay 21, 2026
HARVARD PILGRIM HEALTH CARE INC1$31.7MMar 30, 2026
TOXICOLOGIC PATHOLOGY ASSOCIATES INC1$26.1MSep 15, 2025
IHRC, INCORPORATED1$14.5MSep 16, 2026
VITALANT Scottsdale AZ 85258 USA1$10.0MSep 8, 2025
WE PHARMA, INC.1$4.0MSep 11, 2026
THE BIONETICS CORP1$2.8MJul 21, 2025

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.

Latest awards

Competitive landscape

For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 0 of these past winners lobbied Food & Drug Administration (FDA) since 2024 (0 filings)
  • 0 of their lobbyists list a past Food & Drug Administration (FDA) job
  • No corporate PAC money from them to the overseeing committees since 2024
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 129 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.

  • 0 of the past winners are listed companies
  • 0 insider buys and 0 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.